<!DOCTYPE html><html><head><title>Help for package ClinicalTrialSummary</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {ClinicalTrialSummary}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#ClinicalTrialSummary-internal'><p>Internal Functions for Summary Measures for Clinical Trials with Survival Outcomes</p></a></li>
<li><a href='#ClinicalTrialSummary-package'>
<p>Summary Measures for Clinical Trials with Survival Outcomes</p></a></li>
<li><a href='#ggas'><p>Data from Gastrointestinal Tumor Study Group (1982)</p></a></li>
<li><a href='#ypsummary'><p>The main function of the package provides five summary measures of the treatment effect for clinical trials.</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Summary Measures for Clinical Trials with Survival Outcomes</td>
</tr>
<tr>
<td>Version:</td>
<td>1.1.1</td>
</tr>
<tr>
<td>Author:</td>
<td>Daewoo Pak and Song Yang</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Daewoo Pak &lt;heavyrain.pak@gmail.com&gt;</td>
</tr>
<tr>
<td>Description:</td>
<td>Provides estimates of several summary measures for clinical trials including
    the average hazard ratio, the weighted average hazard ratio, the restricted 
    superiority probability ratio, the restricted mean survival difference and 
    the ratio of restricted mean times lost, based on the short-term and 
    long-term hazard ratio model (Yang, 2005 &lt;<a href="https://doi.org/10.1093%2Fbiomet%2F92.1.1">doi:10.1093/biomet/92.1.1</a>&gt;) 
    which accommodates various non-proportional hazards scenarios. The inference
    procedures and the asymptotic results for the summary measures are discussed 
    in Yang (2018, &lt;<a href="https://doi.org/10.1002%2Fsim.7676">doi:10.1002/sim.7676</a>&gt;).</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-3">GPL (&ge; 3)</a></td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>LazyData:</td>
<td>true</td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>6.1.1</td>
</tr>
<tr>
<td>Imports:</td>
<td>Rcpp</td>
</tr>
<tr>
<td>LinkingTo:</td>
<td>Rcpp</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>yes</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2019-01-18 17:13:07 UTC; dpak</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2019-01-18 21:40:04 UTC</td>
</tr>
</table>
<hr>
<h2 id='ClinicalTrialSummary-internal'>Internal Functions for Summary Measures for Clinical Trials with Survival Outcomes</h2><span id='topic+ClinicalTrialSummary-internal'></span><span id='topic+fun_ahrf'></span><span id='topic+fun_ahrypt'></span><span id='topic+fun_ahryptwo'></span><span id='topic+fun_estimate'></span><span id='topic+fun_mdypt'></span><span id='topic+fun_mrypt'></span><span id='topic+fun_rspypt'></span><span id='topic+fun_less'></span><span id='topic+fun_digit'></span><span id='topic+ransamf'></span>

<h3>Description</h3>

<p>Internal functions for the ClinicalTrialSummary package.
</p>

<hr>
<h2 id='ClinicalTrialSummary-package'>
Summary Measures for Clinical Trials with Survival Outcomes
</h2><span id='topic+ClinicalTrialSummary-package'></span>

<h3>Description</h3>

<p>ClinicalTrialSummary provides estimates of several summary measures of the treatment effect for design and analysis of clinical trials with survival outcomes, introduced in Yang (2018). These estimates are obtained under the short-term and long-term hazard ratio model (Yang and Prentice, 2005) which allows a range of time-varying hazard ratio shapes including crossing hazards situations.
</p>
<p>Let <code class="reqn">hr(x) = \lambda_{t}(x)/\lambda_{c}(x)</code> be the hazard ratio function, where <code class="reqn">\lambda_{t}(x)</code> and <code class="reqn">\lambda_{c}(x)</code> are the hazard functions for the treatment group and the control group, respectively. The main function of the package, <code><a href="#topic+ypsummary">ypsummary</a></code>, provides following five summary measures:
</p>

<ul>
<li><p> the average hazard ratio (AHR): <code class="reqn">\int  hr(x) dx</code>
</p>
</li>
<li><p> the weighted average hazard ratio (WAHR): <code class="reqn">\int hr(x) dw(x)</code> where <code class="reqn">dw(x) = dF_c(x)/F_c(\tau)</code>
</p>
</li>
<li><p> the restricted superiority probability ratio (RSPR): <code class="reqn">\frac{\int S_c(x) dF_t(x)}{\int St(x) dF_c(x)}</code>
</p>
</li>
<li><p> the restricted mean survival difference (RMSD): <code class="reqn">\int S_t(x) dx - \int S_c(x) dx</code>
</p>
</li>
<li><p> the ratio of restricted mean times lost (RRMTL): <code class="reqn">\frac{\tau - \int S_t(x) dx}{\tau - \int S_c(x) dx}</code>
</p>
</li></ul>

<p>Note that  all integrals are taken over <code class="reqn">(0, \tau)</code> for <code class="reqn">\tau</code> less than or equal to the maximum follow-up duration of the trial. The asymptotic results for the average hazard ratio and the restricted mean survival difference were established in Yang and Prentice (2011) and Yang (2013), respectively. For other measures, the asymptotic results were established in Yang (2018).
</p>
<p>The data used as an example in this package was from Gastrointestinal Tumor Study Group (1982) and the object returned by <code><a href="#topic+ypsummary">ypsummary</a></code> can be formatted to a table using the function <code><a href="base.html#topic+summary">summary</a></code>.
</p>


<h3>Details</h3>


<table>
<tr>
 <td style="text-align: left;">
Package: </td><td style="text-align: left;"> ClinicalTrialSummary</td>
</tr>
<tr>
 <td style="text-align: left;">
Type: </td><td style="text-align: left;"> Package</td>
</tr>
<tr>
 <td style="text-align: left;">
Version: </td><td style="text-align: left;"> 1.0.0</td>
</tr>
<tr>
 <td style="text-align: left;">
Date: </td><td style="text-align: left;"> 2018-12-19</td>
</tr>
<tr>
 <td style="text-align: left;">
License: </td><td style="text-align: left;"> GPL (&gt;= 3)</td>
</tr>
<tr>
 <td style="text-align: left;">
</td>
</tr>

</table>



<h3>Author(s)</h3>

<p>Daewoo Pak and Song Yang
</p>


<h3>References</h3>

<p>Yang, S. (2018). Improving testing and description of treatment effect in clinical trials with survival outcomes. Statistics in medicine.
</p>
<p>Yang S, and Ross L. Prentice (2005). Semiparametric analysis of short-term and long-term hazard ratios with two-sample survival data. Biometrika, 92.1:1-17.
</p>
<p>Yang S, and Ross L. Prentice (2011). Estimation of the 2-sample hazard ratio function using a semiparametric model. Biostatistics, 12.2:354-368.
</p>
<p>Yang S. (2013). Semiparametric inference on the absolute risk reduction and the restricted mean survival difference in clinical trials. Special issue on risk assessment. Lifetime Data analysis, 19:219-241.
</p>
<p>Gastrointestinal Tumor Study Group (1982). A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer.
</p>


<h3>See Also</h3>

<p><code><a href="#topic+ypsummary">ypsummary</a></code>
</p>


<h3>Examples</h3>

<pre><code class='language-R'>	library(ClinicalTrialSummary)
	data(ggas)
	result &lt;- ypsummary(time=ggas$time, event=ggas$event, group=ggas$group, tau = 8.2)
	print(result)
	summary(result)
</code></pre>

<hr>
<h2 id='ggas'>Data from Gastrointestinal Tumor Study Group (1982)</h2><span id='topic+ggas'></span>

<h3>Description</h3>

<p>The Gastrointestinal Tumor Study Group (1982) compared chemotherapy with combined chemotherapy and radiation therapy, in the treatment of locally unresectable gastric cancer. Each treatment arm had 45 patients, with  two observations of the chemotherapy group and six of the combination group censored. The plot of Kaplan-Meier survival curves show that the two curves cross at around 1000 days.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>data(ggas)</code></pre>


<h3>Format</h3>

<p>The data has the following information for the ninety subjects:
</p>

<dl>
<dt><code>time</code></dt><dd><p>the vector for the pooled lifetimes of the two groups</p>
</dd>
<dt><code>event</code></dt><dd><p>the numeric vector of the right-censoring indicator (event = 1, censored = 0)</p>
</dd>
<dt><code>group</code></dt><dd><p>the numeric vector of the group indicator (treatment = 1, control = 0)</p>
</dd>
</dl>



<h3>References</h3>

<p>Gastrointestinal Tumor Study Group (1982). A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer.
</p>


<h3>See Also</h3>

<p><code><a href="#topic+ypsummary">ypsummary</a></code></p>


<h3>Examples</h3>

<pre><code class='language-R'>library(ClinicalTrialSummary)
data(ggas)
</code></pre>

<hr>
<h2 id='ypsummary'>The main function of the package provides five summary measures of the treatment effect for clinical trials.</h2><span id='topic+ypsummary'></span><span id='topic+ypsummary.default'></span><span id='topic+summary.ypsummary'></span><span id='topic+print.ypsummary'></span>

<h3>Description</h3>

<p><code>ypsummary</code> provides estimates of several summary measures of the treatment effect for design and analysis of clinical trials with survival outcomes, introduced in Yang (2018). The function utilizes the short-term and long-term hazard ratio model proposed in Yang and Prentice (2005), which can acccomodate various nonproportional hazard scenarios. The asymptotic properties of the summary measures are also discussed in Yang and Prentice (2011), Yang (2013), and Yang (2018).
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## Default S3 method:
ypsummary(time, event, group, tau, alpha = 0.05, tie = TRUE, 
    bound = 50, repnum = 2000, ...)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="ypsummary_+3A_...">...</code></td>
<td>
<p>for S4 method only.</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_time">time</code></td>
<td>
<p>A numeric vector of observations pooled from the two groups</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_event">event</code></td>
<td>
<p>A numeric vector of the right-censoring indicator (event = 1, censored = 0)</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_group">group</code></td>
<td>
<p>A numeric vector of the group indicator (treatment = 1, control = 0)</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_tau">tau</code></td>
<td>
<p>the upper end of the range used in defining the summary measures. Must be user-specified.</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_alpha">alpha</code></td>
<td>
<p>Significance level. The default value is 0.05.</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_tie">tie</code></td>
<td>
<p>The default is <code>TRUE</code>. Add very tiny values to the observations when sorting them to avoid ties.</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_bound">bound</code></td>
<td>
<p>A boundary (<code>-bound</code>, <code>bound</code>) for estimating the parameters in the short-term and long-term hazard ratio model (Yang and Prentice, 2005). These parameters are <code class="reqn">\beta_1</code> and <code class="reqn">\beta_2</code> in their notations. The default boundary is <code class="reqn">(-50, 50)</code>.</p>
</td></tr>
<tr><td><code id="ypsummary_+3A_repnum">repnum</code></td>
<td>
<p>the number of replications for the resampling method in obtaining the limiting variance estimators of the measures. The default value is 2000.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The function <code>ypsummary</code> provides five summary measures of the treatment effect (see, Yang 2018), which can be utilized for various nonproportional haards scenarios:
</p>

<ul>
<li><p> the average hazard ratio (AHR): <code class="reqn">\int  hr(x) dx</code>
</p>
</li>
<li><p> the weighted average hazard ratio (WAHR): <code class="reqn">\int hr(x) dw(x)</code> where <code class="reqn">dw(x) = dF_c(x)/F_c(\tau)</code>
</p>
</li>
<li><p> the restricted superiority probability ratio (RSPR): <code class="reqn">\frac{\int Sc(x) dF_t(x)}{\int S_t(x) dF_c(x)}</code>
</p>
</li>
<li><p> the restricted mean survival difference (RMSD): <code class="reqn">\int S_t(x) dx - \int S_c(x) dx</code>
</p>
</li>
<li><p> the ratio of restricted mean times lost (RRMTL): <code class="reqn">\frac{\tau - \int S_t(x) dx}{\tau - \int S_c(x) dx}</code>
</p>
</li></ul>

<p>where <code class="reqn">hr(x)</code> is the hazard ratio of the treatment group over the control group, <code class="reqn">F_t(x)</code> and <code class="reqn">F_c(x)</code> are the distribution functions for the treatment group and control group, respectively, and <code class="reqn">S_t(x) = 1 - F_t(x)</code> and <code class="reqn">S_c(x) = 1 - F_c(x)</code>. Note that all integrals are taken from 0 to <code class="reqn">\tau</code>. 
</p>


<h3>Value</h3>

<table>
<tr><td><code>Estimate</code></td>
<td>
<p>The point estimate for the corresponding summary meausure</p>
</td></tr>
<tr><td><code>CI</code></td>
<td>
<p>The confidence interval constructed by a re-sampling method. If the measure is a ratio, the z-value is the standardized log of the estimate. If the measure is a difference, the z-value is the standardized estimate.</p>
</td></tr>
<tr><td><code>z-value</code></td>
<td>
<p>Normally distributed value derived from the asymptotic results</p>
</td></tr>
<tr><td><code>p-value</code></td>
<td>
<p>the (two-sided) p-value using <code>z-value</code></p>
</td></tr>
</table>


<h3>References</h3>

<p>Yang, S. (2018). Improving testing and description of treatment effect in clinical trials with survival outcomes. Statistics in medicine.
</p>
<p>Yang S, and Ross L. Prentice (2005). Semiparametric analysis of short-term and long-term hazard ratios with two-sample survival data. Biometrika, 92.1:1-17.
</p>
<p>Yang S, and Ross L. Prentice (2011). Estimation of the 2-sample hazard ratio function using a semiparametric model. Biostatistics, 12.2:354-368.
</p>
<p>Yang S. (2013). Semiparametric inference on the absolute risk reduction and the restricted mean survival difference in clinical trials. Special issue on risk assessment. Lifetime Data analysis, 19:219-241.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>library(ClinicalTrialSummary)
data(ggas)
time &lt;- ggas$time
event &lt;- ggas$event
group &lt;- ggas$group
result &lt;- ypsummary(time, event, group, tau=8.2) # tau must be supplied.
result
summary(result)
</code></pre>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
